[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

TW200716618A - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
TW200716618A
TW200716618A TW095118869A TW95118869A TW200716618A TW 200716618 A TW200716618 A TW 200716618A TW 095118869 A TW095118869 A TW 095118869A TW 95118869 A TW95118869 A TW 95118869A TW 200716618 A TW200716618 A TW 200716618A
Authority
TW
Taiwan
Prior art keywords
chemical compounds
preparation
treatment
proliferative diseases
compounds
Prior art date
Application number
TW095118869A
Other languages
English (en)
Inventor
Kevin Michael Foote
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0510963A external-priority patent/GB0510963D0/en
Priority claimed from GB0600743A external-priority patent/GB0600743D0/en
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of TW200716618A publication Critical patent/TW200716618A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW095118869A 2005-05-28 2006-05-26 Chemical compounds TW200716618A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0510963A GB0510963D0 (en) 2005-05-28 2005-05-28 Chemical compounds
GB0600743A GB0600743D0 (en) 2006-01-14 2006-01-14 Chemical compounds

Publications (1)

Publication Number Publication Date
TW200716618A true TW200716618A (en) 2007-05-01

Family

ID=36753382

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095118869A TW200716618A (en) 2005-05-28 2006-05-26 Chemical compounds

Country Status (7)

Country Link
US (1) US20080194556A1 (zh)
EP (1) EP1888572A1 (zh)
JP (1) JP2008542345A (zh)
AR (1) AR056369A1 (zh)
TW (1) TW200716618A (zh)
UY (1) UY29561A1 (zh)
WO (1) WO2006129064A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100491372C (zh) * 2001-12-24 2009-05-27 阿斯特拉曾尼卡有限公司 作为欧若拉激酶抑制剂的取代喹唑啉衍生物
GB0601215D0 (en) * 2006-01-21 2006-03-01 Astrazeneca Ab Chemical compounds
US9101631B2 (en) 2008-12-12 2015-08-11 Georgetown University Combination therapy based on SRC and aurora kinase inhibition for the treatment of cancer
ES2541054T3 (es) * 2010-10-20 2015-07-15 Université De Bordeaux Firmas del resultado clínico en tumores estromales gastrointestinales y método de tratamiento de tumores estromales gastrointestinales
WO2014103947A1 (ja) 2012-12-25 2014-07-03 日本曹達株式会社 ハロゲン化アニリンおよびその製造方法
AU2014353006B2 (en) 2013-11-20 2019-04-04 Signalchem Life Sciences Corp. Quinazoline derivatives as TAM family kinase inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0409427A (pt) * 2003-04-16 2006-04-18 Astrazeneca Ab composto, uso do mesmo, composição farmacêutica, método de tratamento de um humano sofrendo de uma doença hiperproliferativa, e, processo para a preparação de um composto ou de um sal, éster ou pró-droga farmaceuticamente aceitáveis do mesmo

Also Published As

Publication number Publication date
UY29561A1 (es) 2006-12-29
JP2008542345A (ja) 2008-11-27
AR056369A1 (es) 2007-10-10
EP1888572A1 (en) 2008-02-20
WO2006129064A1 (en) 2006-12-07
US20080194556A1 (en) 2008-08-14

Similar Documents

Publication Publication Date Title
UY29562A1 (es) Compuestos heterocíclicos de amino benzoilo, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
TW200640908A (en) Chemical compounds
TW200508214A (en) Novel compounds
MXPA05011076A (es) Derivados de quinazolina para el tratamiento de cancer.
WO2007087548A3 (en) Chemical compounds
TW200800999A (en) Novel compounds
TW200738659A (en) Novel compounds
WO2006096444A3 (en) Chemical compounds
DE602004021472D1 (en) Pyrimiidinverbindungen
SE0202539D0 (sv) Compounds
IL184872A0 (en) Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers
IL185063A0 (en) Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers
TW200716606A (en) Chemical compounds
TW200800963A (en) Chemical compounds
TW200639156A (en) New compounds
TW200745084A (en) Novel compounds
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
TW200616995A (en) Novel compounds
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
TW200505452A (en) Chemical compounds
WO2007009721A3 (en) Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments
MX2009006010A (es) Derivados de amina y su uso en enfermedades mediadas por el adrenoreceptor beta 2.
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
TW200716618A (en) Chemical compounds
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли